2)指標優(yōu)于對照組,差異有統(tǒng)計學(xué)意義(P<0.05)。治療10 d后患者FEV1/L和FEV1/FVC指標均顯著改善,同組治療前后比較差異有統(tǒng)計學(xué)意義(P<0.05);且觀察組患者FEV1/L和FEV1/FVC指標優(yōu)于對照組,差異有統(tǒng)計學(xué)意義(P<0.05)。治療后,兩組患者的痰液和血液中丙二醛濃度較治療前顯著降低,同組治療前后比較差異有統(tǒng)計學(xué)意義(P<0.05);且觀察組患者血液丙二醛濃度低于對照組,差異有統(tǒng)計學(xué)意義(P<0.05)。結(jié)論 疏風(fēng)解毒膠囊聯(lián)合西醫(yī)常規(guī)治療有利于改善AECOPD患者肺功能指標,減輕患者臨床癥狀。;Objective To evaluate the efficacy of Shufeng Jiedu Capsule combined with western medicine in the pulminary function of AECOPD patients. Methods 70 patients with AECOPD were choosed and randomly divided into study group and observation group, which group were 50 cases respectively. The control group was treated with routine treatment of Western Medicine. The observation group patients were treated in routine treatment combined with Shufeng Jiedu Capsule. After 10 days treatment, compared the two groups of changes in arterial blood gas, lung function, sputum and malondialdehyde in blood. Results After treatment, blood gas analysis of two groups of patients were improved significantly (P<0.05), and the arterial partial pressure of oxygen (PaO2) index in observation group is better than the control group (P<0.05). After treatment, the observation group FEV1/L and FEV1/FVC index is better than the patients in the control group (P<0.05), and the concentrations of malondialdehyde in sputum and blood of two groups were significantly lower than those before treatment (P<0.05), and the concentration of malondialdehyde in the observation group was lower than that in the control group (P<0.05).Conclusion Shufeng Jiedu Capsule combined with western medicine is beneficial to improve the pulmonary function index of AECOPD patients and reduce the clinical symptoms of the patients."/>

醉酒后少妇被疯狂内射视频,一本色道久久综合一,在线天堂新版资源www在线下载,中文字幕乱人伦高清视频,中字幕视频在线永久在线观看免费

首頁 > 過刊瀏覽>2018年第41卷第10期 >2018,41(10):1867-1870. DOI:10.7501/j.issn.1674-6376.2018.10.024
上一篇 | 下一篇

評價疏風(fēng)解毒膠囊聯(lián)合西醫(yī)治療對慢性阻塞性肺疾病急性加重期患者肺功能的影響

Effect of Shufeng Jiedu Capsule combined with western medicine in the pulmonary function of AECOPD patients

發(fā)布日期:2018-10-22
您是第位訪問者
藥物評價研究 ® 2025 版權(quán)所有
技術(shù)支持:北京勤云科技發(fā)展有限公司
津備案:津ICP備13000267號 互聯(lián)網(wǎng)藥品信息服務(wù)資格證書編號:(津)-非經(jīng)營性-2015-0031